Position in CSLLY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,050
+$191 QoQ
Shares Held
165
+23.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CSLLY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $99,745,787 across 265 Biotechnology names. CSLLY ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
71,942 | $32,124,978 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,226 | $14,082,131 | |
| 3 | TECH |
BIO-TECHNE Corp
|
93,722 | $4,897,909 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,322 | $4,076,976 | |
| 5 | MRNA |
Moderna, Inc.
|
69,883 | $3,550,054 | |
| 6 | INCY |
Incyte Corp
|
33,976 | $3,197,817 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
37,360 | $3,135,250 | |
| 8 | ARGX |
Argenx SE
|
3,796 | $2,772,027 |
All Filings in CSLLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,050 | 165 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,859 | 134 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $5,109 | 156 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $6,890 | 174 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,025 | 203 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $7,617 | 174 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $7,853 | 159 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $6,944 | 141 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $6,647 | 141 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,822 | 161 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $6,298 | 156 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $22,050 | 478 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $22,365 | 463 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,019 | 472 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $31,298 | 686 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $34,086 | 741 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $31,371 | 629 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $25,179 | 476 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,764 | 454 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $24,300 | 457 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $12,909 | 255 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $10,959 | 199 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,288 | 199 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $10,433 | 209 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $11,013 | 241 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||